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Abstract:  
 
Context:  Women are 2 to 8 times more likely to sustain an anterior cruciate ligament (ACL) 
injury than men, and previous studies indicated an increased risk for injury during the 
preovulatory phase of the menstrual cycle (MC). However, investigations of risk rely on 
retrospective classification of MC phase, and no tools for this have been validated. 
Objective:  To evaluate the accuracy of an algorithm for retrospectively classifying MC phase 
at the time of a mock injury based on MC history and salivary progesterone (P4) concentration. 
Design:  Descriptive laboratory study. 
Setting:  Research laboratory. 
Participants:  Thirty-one healthy female collegiate athletes (age range, 18−24 years) provided 
serum or saliva (or both) samples at 8 visits over 1 complete MC. 
Main Outcome Measure(s):  Self-reported MC information was obtained on a randomized 
date (1−45 days) after mock injury, which is the typical timeframe in which researchers have 
access to ACL-injured study participants. The MC phase was classified using the algorithm as 
applied in a stand-alone computational fashion and also by 4 clinical experts using the algorithm 
and additional subjective hormonal history information to help inform their decision. To assess 
algorithm accuracy, phase classifications were compared with the actual MC phase at the time of 
mock injury (ascertained using urinary luteinizing hormone tests and serial serum P4 samples). 
Clinical expert and computed classifications were compared using κ statistics. 
Results:  Fourteen participants (45%) experienced anovulatory cycles. The algorithm correctly 
classified MC phase for 23 participants (74%): 22 (76%) of 29 who were 
preovulatory/anovulatory and 1 (50%) of 2 who were postovulatory. Agreement between expert 
and algorithm classifications ranged from 80.6% (κ = 0.50) to 93% (κ = 0.83). Classifications 
based on same-day saliva sample and optimal P4 threshold were the same as those based on MC 
history alone (87.1% correct). Algorithm accuracy varied during the MC but at no time were 
both sensitivity and specificity levels acceptable. 
Conclusions:  These findings raise concerns about the accuracy of previous retrospective MC-
phase classification systems, particularly in a population with a high occurrence of anovulatory 
cycles. 
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Article:  
 
Key Points 
 
 Neither the algorithm nor our clinical expert assessment was able to accurately predict 
menstrual-cycle (MC) phase at the time of injury. In particular, specificity of the 
postovulatory phase could not be adequately assessed due to the high number of 
anovulatory cycles observed. 
 
 These findings raise substantial questions regarding the accuracy of retrospectively 
determining the MC phase of young athletes, with or without a hormone measurement, in 
prior investigations, particularly in a population with a high occurrence of anovulatory 
cycles and a large prevalence of luteal-phase defects. 
 
 Accurate determination of MC phase may only be possible through a prospective 
examination that captures estradiol and progesterone concentrations over multiple days 
before and after injury, which may not be logistically feasible in injury or disease risk-
factor investigations in this population. 
 
 These findings are particularly important for any investigation designed to retrospectively 
characterize MC phase and its association with injury or disease in this population. 
 
Rupture of the anterior cruciate ligament (ACL) produces substantial disability and greatly 
increases the risk of early-onset posttraumatic osteoarthritis. Consequently, much effort has 
focused on identifying risk factors that predispose individuals to ACL injury. Although the risk 
of ACL injury is likely multifactorial,[1,2] a substantial body of literature[3−12] suggests that 
risk may differ across phases of a female's menstrual cycle (MC). Sex-hormone concentrations 
are known to vary widely across days of the MC, and previous investigations have shown how 
normal physiologic changes in hormone concentrations can affect collagen metabolism[13] and 
ligament behavior[14]; they may also influence knee laxity, but the evidence for this in the 
literature is conflicting.[14,15] Sex-hormone fluctuations may subsequently influence other 
suspected ACL injury risk factors in a cyclic manner (eg, serum relaxin levels,[16] 
musculotendinous stiffness,[17] and knee-valgus motion[15]). 
 
Multiple investigators[3−12] have examined the relationship between MC phase and the risk of 
sustaining an ACL injury. The consensus of these authors is that the risk of ACL injury may be 
disproportionately higher during the preovulatory phase, with some noting a higher proportion of 
injuries near menses, whereas others noted a higher proportion near ovulation.[5,6,9,18] Because 
of their retrospective designs, most of these researchers characterized MC phase based on 
historical data about a female's MC combined with calendar-counting methods.[3,4,6−9,11] 
These retrospective methods are limited in their ability to accurately identify the hormonal 
milieu (and hence MC phase) at the time of injury due to inconsistencies in participant recall[12] 
and variability in MC characteristics (eg, timing of hormone changes), even among those with 
28- to 32-day cycles.[19,20] These limitations are particularly concerning when the injury event 
occurs near menses or ovulation, when hormone values are changing rapidly. To address these 
limitations, the authors[5,10,12] of 3 studies evaluated hormone concentrations soon after injury 
(2 to 72 hours) and found a greater-than-expected proportion of injuries near menses,[10] 
ovulation,[12] and more generally in the preovulatory phase.[5] Although hormone 
measurements were thought to increase the accuracy of phase determinations,[5,12] the sources 
of hormone data differed in these 3 studies, and the methods used to classify MC phase were not 
validated. In addition, it may not always be feasible to obtain hormone samples so near the time 
of injury. 
 
Despite their limitations, case-control studies may be the only practical approach for exploring 
relationships between MC phase and injury risk. However, we are not aware of any studies that 
have compared information obtained at or after injury with that obtained prospectively to assess 
the validity of this approach. To conduct such an investigation, we formulated an algorithm 
based on retrospectively acquired hormonal and menstrual-history data and salivary progesterone 
concentrations to approximate the methods used to classify MC phase in previous retrospective 
ACL-injury risk-factor studies. We then comprehensively evaluated the algorithm's ability to 
determine MC phase (preovulatory versus postovulatory) retrospectively at the time a mock 
injury (or event) occurred using prospectively acquired data to determine true menstrual phase 
on the date of mock injury. We also determined if different investigators, who may be influenced 
by their own clinical judgment, could reliably apply the algorithm. We expected that the 
algorithm would yield consistent results across investigators but that accurate classification of 
MC phase at the time of mock injury would be a challenge. Our evaluation therefore included an 
examination of how salivary progesterone (P4) and the timing of sample collection influence 
algorithm performance. We also examined whether the algorithm's accuracy varied depending on 
when during the MC the mock injury occurred. 
 
MENSTRUAL-PHASE ALGORITHM 
 
An algorithm was developed to categorize participants as preovulatory or postovulatory at the 
time of injury using self-reported menstrual history and a salivary P4 concentration obtained 
after the injury date (Figure). This algorithm was based on published data[21−23] regarding MCs 
in young women, as well as clinical experience. Similar to many of the methods based on 
calendar counting, the algorithm assumes that the length of the luteal phase is more stable than 
that of the follicular phase, with ovulation usually occurring 14 days before the onset of menses. 
In accordance with published data,[22,24] a salivary P4 concentration of 190 pmol/L was 
selected as the threshold indicating that ovulation occurred. Participants with injuries occurring 
within 14 days of the next menses are considered anovulatory if their P4 values are below the 
190 pmol/L threshold and their observed cycle is 3 or more days shorter or longer than their 
normally reported MC length. 
 
 
Figure. Mathematical menstrual-cycle phase classification algorithm. Abbreviation: P4, 
Progesterone concentration. 
 
METHODS 
 
Thirty-three National Collegiate Athletic Association Division I female athletes between the ages 
of 18 and 24 years from the University of Vermont were examined in this study. All participants 
reported a normal MC history, no use of prescription medications or illicit substances, no use of 
tobacco over the past 12 months, and good overall health with no underlying conditions. They 
also met a weekly physical activity energy expenditure of 60 kcal/kg/wk or greater during 
moderate-, high-, and very high-intensity activities.[25] Normal MC history was defined as >25 
days and <40 days between cycles with no change in menstrual status in the past 12 months. 
Energy expenditure during physical activity was measured with the 7-Day Physical Activity 
Recall (PAR).[25] Our institutional review board approved this investigation, and all participants 
provided written informed consent before enrollment. 
 
Prospective Characterization of the MC 
 
Participants visited the laboratory on 8 occasions, spaced equally over the course of 1 MC. The 
first day of testing began within 24 hours of the onset of menses, and spacing of subsequent 
visits was based on the length of her previous MC, which was defined as the number of days 
from the first day of bleeding during the previous MC to the last day before the onset of bleeding 
of the next MC. During visits 1, 3, 5, and 7, participants provided saliva and serum samples. At 
visits 2, 4, 6, and 8, subjects provided saliva samples and completed the PAR 
questionnaire.[25,26] Unless the next menses began before visit 8, its start date was obtained 
through telephone contact. 
 
Salivary Sample Collection and Analysis. We instructed participants to abstain from consuming 
alcohol for 12 hours before sample collection and consuming anything by mouth (except water) 
or chewing gum for a minimum of 1 hour before each visit and to refrain from flossing their 
teeth between waking and their laboratory visit. These restrictions normalize salivary pH and 
avoid potential blood contamination. A minimum of 10 minutes before collection, participants 
rinsed their mouths with water 3 times for 10 seconds per rinse to remove food particulates and 
normalize salivary pH.[27,28] Approximately 4 mL of whole, nonstimulated saliva was collected 
by passive drool through a 5-cm long plastic straw. Samples were stored at −80°C until shipment 
to the Oregon National Primate Research Center (ONPRC) at Oregon Health Sciences University 
for analysis using Salimetrics Salivary Progesterone immunoassay kits (Salimetrics LLC, State 
College, PA). The intra-assay and interassay coefficients of variation (CVs) for this assay as 
performed by ONPRC were 5.63% and 8.37%, respectively. 
 
Serum Sample Collection and Analysis. We obtained approximately 8-mL samples of whole 
blood via standard venipuncture and stored them at −80°C until they were shipped to ONPRC for 
analysis. Serum P4 was analyzed in duplicate on an Immulite 2000 (Siemens Healthcare, 
Munich, Germany) automated clinical immunoassay system. Intra-assay and interassay CVs 
were less than 10%. 
 
Assessment of Day of Ovulation. Starting on day 8 of their MCs, participants were instructed to 
perform non–first-morning void luteinizing hormone-based ovulation tests (Kurkel Enterprises, 
LLC, Redmond, WA) to detect the rise in urinary luteinizing hormone that indicates ovulation 
date. The tests were to be used at the same time each day, between 11:00 am and 8:00 pm as 
recommended by the manufacturer. Each participant underwent 2 educational sessions regarding 
ovulation test procedures and result documentation before beginning the tests. Results were 
recorded on a log sheet and discussed with investigators at each visit to ensure accurate 
documentation and compliance. Tests were either stopped after a positive result or continued 
until the first day of menstruation during the subsequent cycle. If a test was considered invalid 
(ie, inconclusive or suspected to be faulty), we instructed participants to repeat it at the next 
normal void. 
 
Assignment of Mock-Injury Date. At the time of enrollment, participants were randomly assigned 
a mock-injury event date that would be subsequently used to evaluate the algorithm's accuracy in 
identifying the MC phase at time of injury. In an effort to simulate the recall of the date of 
significant musculoskeletal trauma, such as an ACL tear, participants were not informed of the 
mock injury until the scheduled date, when they were given a brightly colored bracelet 
displaying the date in large, bold text. They were not required to wear the bracelet; however, 
they were asked to place it in a location they would observe multiple times throughout the day. 
At each subsequent visit, we stressed the importance of this mock-injury date. The motivation for 
providing a date-inscribed item and stressing the importance of remembering the date was to 
create a memorable event date that would serve as a surrogate for the point in time when an 
athlete actually sustained a significant injury. 
 
Retrospective Classification of MC Phase 
 
To assess the accuracy of the algorithm to retrospectively determine MC phase at the time of 
mock injury, participants were interviewed by an investigator (K.J.T.) who was blinded to all 
aspects of the study relating to MC characterization. She acquired MC information using a 
modified version of the Hormonal History Questionnaire (HHQ), which has been previously 
validated and applied.[12] The HHQ information included average MC length, normal days of 
menstruation, date of the first day of the last menstrual period, average number of days between 
periods, number of menstrual periods in the past 12 months, premenstrual symptoms and their 
severity, use of hormonal therapies of any kind, and the date of the mock injury. Random 
numbers (1−45) were assigned to specify the number of days after the mock injury that attempts 
to contact the participant and administer the HHQ could begin. This was done to replicate, as 
best as possible, real-world variations in the time between injury and enrollment in a 
retrospective case-control investigation, because the recall accuracy of HHQ information for a 
particular MC declines as time progresses.[29] Similarly, in most studies of ACL injury risk, it is 
not always possible to obtain a saliva sample on the day of injury. We therefore randomly 
selected a salivary sample from among those obtained on or after the mock-injury date but before 
the start of the next menses. 
 
The algorithm was applied to these retrospectively acquired data using 2 methods to classify MC 
phase at the time of mock injury. First, it was applied in a purely objective fashion using a 
sequence of yes/no responses (Figure). Second, 4 investigators (S.J.S., I.M.B., D.M.H., J.R.S.) 
applied the algorithm using the same salivary P4 concentrations and self-reported menses dates. 
The investigators had backgrounds typical of researchers interested in studying the relationship 
between MC phase and injury risk. 
 
Algorithm Validation 
 
To determine the validity of the algorithm when applied purely objectively and then by each of 
the 4 investigators, each woman's assignment into the preovulatory or postovulatory phase of the 
MC at the time of the mock injury was compared with her known phase on that date as 
determined by an expert in reproductive medicine (I.M.B.) using the prospectively acquired data 
(luteinizing hormone-based ovulation detection kits, serial serum P4 concentrations, and menses 
dates). We conducted secondary analyses to examine whether algorithm accuracy could be 
improved by using salivary P4 samples obtained on the mock-injury date or by modifying the 
algorithm to include MC-history information only. To determine how the timing of injury during 
an MC influences algorithm performance, we examined its accuracy when each of the 8 visits 
was selected as the mock-injury date. Salivary P4 concentrations were analyzed using mixed-
model linear regression to test the differences between MC phases and estimate within-person 
and between-persons variability. 
The following accuracy measures were computed. Sensitivity was the proportion of women in the 
preovulatory phase who were correctly classified as preovulatory. Specificity was the proportion 
of women in the postovulatory phase who were correctly classified as postovulatory. Positive 
predictive value (PPV) was the proportion of women classified as preovulatory who were 
actually in the preovulatory phase. Negative predictive value (NPV) was the proportion of 
women classified as postovulatory who were actually in the postovulatory phase. Overall 
accuracy was the proportion of all women who were correctly classified. 
 
We used κ statistics to assess agreement in phase assignments between investigators and the 
mathematical algorithm. Pearson product moment correlation was used to examine the 
relationship between salivary and serum P4 concentrations. All data analyses were performed 
using SAS (version 9.2; SAS Institute Inc, Cary, NC). 
 
RESULTS 
 
Two athletes were excluded during the course of the study: 1 participant did not complete all 
data-collection requirements, and 1 had an average PAR <60 kcal/kg/wk during the 4-week 
testing interval. Demographics for the remaining 31 women are listed in Table 1; their average 
PAR score was 78.9 ± 30.2 kcal/kg/wk. Overall, the mean salivary P4 concentration was higher 
for samples obtained during the postovulatory phase (as determined based on prospectively 
acquired serum samples and ovulation tests) than for samples obtained during the preovulatory 
phase and from anovulatory women (Table 2). However, the estimated within-phase variability 
for samples taken from the same woman (CV = 0.50) was as large as the variability between 
phases (CV = 0.49) and much larger than the variability among women (CV = 0.31). The overall 
correlation between salivary and serum P4 concentrations taken on the same day was R = 0.71. 
 
Table 1. Participant Demographics (N=31) 
 
 
 
Menstrual-cycle length ranged from 19 to 60 days (mean = 31 ± 9.5 days). The mock-injury date 
was, on average, 10.7 days after the onset of menses (range = 0–31 days). The average number 
of days to the next menses after the injury date was 19.8 days. Based on the prospectively 
acquired data, 14 of the 31 participants (45.2%) were anovulatory during the tested cycle, 
whereas 15 (48.4%) were preovulatory and 2 (6.5%) were postovulatory at the time of their 
mock injury. The HHQs were administered an average of 20 days after the mock-injury date 
(range = 6–54 days), and 23 athletes (74%) accurately recalled the starting dates of the menses 
before and after the mock injury. Six participants reported incorrect dates for the menses before 
the mock injury, with differences ranging from −3 to +4 days, and 4 women (including 2 with 
incorrect starting dates) incorrectly reported the date of menses after the mock injury, with 
differences ranging from −3 to +5 days. The number of days between the mock injury and the 
randomly selected saliva sample used to evaluate the algorithm ranged from 0 to 35 days 
(median = 10 days). 
 
Table 2. Salivary Progesterone Concentrationsa 
 
 
 
Each athlete's self-reported MC data and salivary P4 concentration from the sample selected for 
use in the algorithm are shown in Table 3, along with the menstrual-phase classification at the 
time of the mock injury as determined by the algorithm, and her actual phase. The sensitivity of 
the algorithm to correctly classify the 29 participants in the preovulatory phase at the time of 
mock injury was 75.9%, whereas its specificity for correctly classifying the 2 postovulatory 
participants was 50% (Table 4). The PPV of a preovulatory/anovulatory classification by the 
algorithm was high (95.6%), due to the high prevalence of this ovulatory phase (93.5%), which 
corresponds to the PPV that would be achieved using a completely random phase assignment. 
The NPV of a postovulatory classification was 12.5%. 
 
One postovulatory woman was incorrectly classified by the algorithm as 
preovulatory/anovulatory because her mock injury occurred after ovulation but more than 14 
days before her next menses. Of the 8 athletes that the algorithm classified as postovulatory at 
the time of injury, only 1 was actually postovulatory, 5 were anovulatory, and 2 were 
preovulatory, as determined prospectively based on serial serum P4 concentrations and ovulation 
tests (Table 3). The 2 preovulatory women (participants 28 and 30) had mock injuries within 14 
days of the next menses but ovulated after the mock-injury date. They both had salivary P4 
concentrations well above 190 pmol/L during their entire cycles, so the timing of their saliva 
samples did not contribute to the misclassification. Of the 5 anovulatory individuals, 2 
(participants 26 and 29) had MCs that were shorter than their average cycles but were classified 
by the algorithm as postovulatory because of their high salivary P4 concentrations. Conversely, 
participants 24 and 25 were misclassified as postovulatory despite their low salivary P4 
concentrations because their MCs were the usual length. Participant 27 was misclassified 
because on the HHQ she erroneously recalled her menses date as being 13 days after the mock-
injury date, though the actual date was 16 days after injury. 
 
Table 4. Accuracy of the Menstral-Phase Algorithm, % 
 
 
 
The menstrual-phase classifications obtained when the 4 investigators applied the algorithm 
differed somewhat from the objectively computed classifications, with agreement ranging from 
80.6% (κ = 0.50, 95% confidence interval = 0.15, 0.84) to 93.5% (κ = 0.83, 95% confidence 
interval = 0.60, 1.00). Sensitivity ranged from 72.4% to 75.9%, which was comparable with the 
mathematically applied algorithm. Three investigators correctly classified 1 of the 2 
postovulatory women (50% specificity), and the fourth correctly classified both (100% 
specificity). 
 
When the objectively computed algorithm was based on saliva samples taken on the date of 
mock injury, rather than the randomly selected sample, accuracy showed little improvement 
(Table 4). The algorithm correctly classified 2 preovulatory/anovulatory athletes who were 
previously misclassified and misclassified 1 preovulatory/anovulatory athlete who had 
previously been classified correctly. Modifying the algorithm so that it was based only on the 
self-reported MC data improved sensitivity to 89%. It also improved both PPV and NPV, but 
NPV and specificity both remained very low (Table 4). 
 
The accuracy of the algorithm varied widely depending on timing of the mock injury (Table 5). 
Sensitivity was highest when the mock injury occurred early in the MC because all or most 
participants were in the preovulatory phase, but it dropped steeply at midcycle, when the 
algorithm classified many preovulatory participants as postovulatory. In contrast, specificity and 
NPV were higher when the mock injury occurred later in the MC. There was no time during the 
MC when both the sensitivity and specificity of the algorithm were acceptable. 
 
DISCUSSION 
 
Because ACL injuries occur infrequently, case-control studies remain the most practical research 
design to explore relationships between MC phase and ACL injury risk. For these retrospective 
studies to be valid, it is necessary to establish an objective procedure (algorithm) to accurately 
classify an individual's MC phase at the time of injury based on data that can be reasonably 
obtained after injury. Consequently, the goal of our study was not to create a novel algorithm but 
rather to evaluate our ability to classify phase using an algorithm based on current MC-phase 
knowledge, as has been used by previous investigators attempting to classify phase after injury. 
Our evaluation of an objective algorithm based on a menstrual-history questionnaire and single 
salivary P4 sample obtained after a mock injury indicates that these data were insufficient for 
accurate retrospective classification of participants as preovulatory/anovulatory versus 
postovulatory at the time of a mock injury. 
 
Table 5. Effect of Injury Timing on Algorithm Performance 
 
 
 
When applied objectively, the algorithm correctly classified only 74% of the 31 participants as 
being preovulatory versus postovulatory at the time of injury. Similar results were obtained when 
experts in the field applied the algorithm, reflecting their 80.6% to 93.5% agreement with the 
objectively applied algorithm. Although this suggests that the algorithm could yield similar 
results from different investigators, it was unable to classify participants with a high degree of 
accuracy. This lack of accuracy may be due to 3 primary sources of error: (1) the inability of 
athletes to correctly recall their menstrual history accurately, (2) assumption of a stable, constant, 
14-day luteal-phase window, and (3) the inability of a single hormone sample to adequately 
capture the large variability in MC characteristics and hormone profiles across women. 
 
The study was designed to initiate contact with study participants for the purpose of acquiring 
menstrual-history data at a random time interval (1−45 days) by a blinded investigator after the 
mock-injury date to mimic real-world situations in which it may not always be feasible to obtain 
data immediately after the injury, particularly in large-scale studies. We were able to make 
contact with the participants and acquire their menstrual-history data between 6 and 54 days after 
the mock injury. These data were then used to identify the start date for the menses occurring 
before and after the mock-injury date. Studies accessing self-reported MC information indicate 
there may be substantial recall error, particularly in younger females who have more variable 
cycle lengths.[30] Moreover, recall error may be particularly problematic if injury occurs near 
midcycle (ie, ovulation), when even a 1-day or 2-day error in menses dates could result in a 
different phase classification. In our study, 23 women (74.2%) correctly recalled the starting 
dates of the menses before and after the date of mock injury. Of the 8 women who erroneously 
reported 1 date or both dates, only 1 was misclassified because of the error, and her mock injury 
occurred midcycle, so recall error was not a major reason for the algorithm's poor performance. 
 
In addition to its potential recall error, self-reported menstrual-history information cannot reveal 
the length of specific MC phases or the timing of ovulation. Although the average MC length is 
28 days and ovulation on average occurs around day 14, the actual length of an individual cycle, 
the timing of ovulation, and thus the length of the follicular and luteal phases are all known to 
vary.[20,21,31−34] Specific to our methods, counting back 14 days from the start of the next 
cycle was based on the assumption that the length of the luteal phase is more consistent than that 
of the follicular phase.[5,9,17,31] Whereas the follicular phase is reported to average 13 to 14 
days in length,[21,31,33] actual luteal-phase lengths range from 11 to 18 days in young females 
aged 18 to 24 years[21] (8−17 in females aged 18−40 years[31,33]). Moreover, some findings 
suggest that exercising women have significantly shorter luteal phases (eg, 8.2 ± 0.5 days).[35] 
In a study of 73 physically active females aged 18 to 30 years,[20] only 32% had a positive 
urinary ovulation test and 59% had attained a P4 level criterion of >2.0 ng/mL when counting 
back 12 to 14 days from the start of the next cycle. Hence, using a standard criterion of 14 days 
to represent the luteal-phase length in physically active women may contribute to the inaccuracy 
of the algorithm. In our study, the phases of 2 participants were misclassified because ovulation 
occurred less than 14 days before the start of the next menses. A summary of previous studies 
examining the relationship between MC phase and ACL injury risk is provided in Table 
6.[3,5,7,8,10] 
 
Table 6. Summary of Menstrual-Cycle Phase Classification Methods for Studies of the 
Relationship Between Phase of the Menstrual Cycle and Risk of Sustaining an Anterior Cruciate 
Ligament Injury 
 
 
 
Given the challenges of these calendar-based methods, more recent investigations of the 
relationship between ACL injury risk and MC phase have evaluated hormonal concentrations 
near the time of injury (<72 hours) to better estimate the actual hormone milieu.[5,10,12] 
However, despite the inclusion of salivary P4 concentration in our algorithm, we were unable to 
achieve an acceptable level of accuracy in MC-phase determination, even when we used the 
sample obtained on the mock-injury date. We suspect this may be due to the choice of a 190-
pmol/L threshold, as P4 concentrations observed in our study were higher than those reported by 
Chatterton et al.22 Yet when we used the optimal threshold for classification in our study (340 
pmol/L) and the saliva sample obtained on the day of injury, sensitivity and specificity were no 
better than when the algorithm was based on self-reported MC data alone. 
 
Use of a single sample to determine MC phase has recently been questioned.[19] Because of the 
inherent variability in MC characteristics, it may be difficult to determine from a single sample 
whether hormone levels are rising, peaking, or falling. Hence, a single sample coupled with the 
known inaccuracies in calendar-based counting methods already discussed may not provide 
sufficient information to accurately identify the phase of the MC at the time of injury. Although 
research suggests that taking multiple samples around the event of interest may provide a better 
representation of the hormonal milieu than a single sample,[34] further study is needed to 
determine if this would improve the determination of MC phase. We did not explore the use of 
multiple salivary P4 samples to determine phase in our study because of their large variability. 
Samples obtained from the same woman differed as much within each MC phase as between 
phases, so she could have a preovulatory sample with a higher P4 concentration than a 
postovulatory sample. 
 
We have 2 concerns regarding the high number of anovulatory cycles that occur in young 
athletic females, despite their normally occurring menses. First, we have concern that an altered 
hormonal milieu may affect their bone health, and this requires further attention. Second, with 
our algorithm, anovulatory participants meeting the third criterion of the algorithm (sample 
below salivary P4 threshold, evidence of menses within 14 days of injury, and onset of menses 
within 2 days of the normal MC length reported in the questionnaire) were incorrectly classified 
as postovulatory. This is particularly problematic for competitive athletes, as our reported 
frequency of anovulatory MCs (45%) was more than twice that for females exercising >2 h/wk at 
55% of maximum heart rate[23] or between 2 and 10 hours for 3 months or longer.[34] It is 
possible that the algorithm could be modified to better distinguish between women in the 
postovulatory phase and those experiencing an anovulatory cycle. However, correct 
classification of women with anovulatory MCs that are of similar length to their usual MCs is 
likely to remain a problem unless more predictive hormone data are available. 
 
Compounding these difficulties is the fact that errors in menstrual-phase assessment are more 
likely when injuries occur at certain times during the MC than others. We demonstrated this by 
examining how the sensitivity and specificity of our algorithm changed with the timing of the 
mock injuries. The accuracy of other methods of phase determination is also likely to vary 
depending on the timing of injury, which is of concern because it indicates that the inaccuracy 
reflects bias as well as imprecision. Although this was not the primary goal of our study, future 
investigators should evaluate the temporal response of sex hormones across multiple MCs, as 
well as the effects of physical and emotional stress on sex-hormone levels in collegiate-aged 
competitive athletes, as this information may aid in the ability to retrospectively classify MC 
phase after musculoskeletal trauma. 
 
Whereas this study was limited to a relatively small sample of collegiate athletes with a high 
percentage of anovulatory cycles, they do represent the high-risk populations typically included 
in ACL injury risk-factor studies. Only 2 of the women were postovulatory at the time of mock 
injury, limiting our ability to assess the specificity with which the algorithm classified these 
individuals. However, the analysis discussed earlier, in which alternative mock-injury dates were 
examined, indicated that postovulatory women were often incorrectly classified unless the injury 
occurred near the end of the MC. 
 
CONCLUSIONS 
 
We showed that an algorithm using a single measurement of salivary P4 concentration to 
retrospectively classify MC phase was not valid for use in risk-factor studies. These findings 
raise substantial questions regarding the accuracy of prior investigations that retrospectively 
determined the MC phases of young athletes based on calendar methods with or without a single 
hormone sample, particularly in a population with such a high occurrence of anovulatory 
cycles.[19] It is possible that accuracy may be improved by acquiring multiple samples 
immediately after the day of injury, but our data indicate that salivary P4 may not be adequate 
for this purpose because of within-phase variability. Ultimately, accurate determination of MC 
phase may only be possible through prospective examination that captures both estradiol and 
progesterone concentrations over multiple days around (ie, both before and after) the time of 
injury. This would be virtually impossible for studies of risk for ACL trauma because a very 
large number of athletes would need to be tested over extended periods of time to accrue an 
adequate sample of injured participants. 
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